Ratings Enlitic, Inc.

Equities

Market Closed - Australian S.E. Other stock markets 09:09:18 27/06/2024 am IST			5-day change	1st Jan Change
0.135 ^AUD	0.00%		-20.59%	-84.30%

17/06	Enlitic Enters New Partnerships with Esaote, Clairvo, DataFirst	MT
03/06	Enlitic Launches New Version of Medical Technology Software	MT

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Sales forecast by analysts have been recently revised upwards.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ENLITIC, INC.	-84.30%	7.75M		-
PRESIGHT AI HOLDING PLC	-2.30%	3.25B	-	-
BEIJING FOURTH PARADIGM TECHNOLOGY CO., LTD.	+5.58%	3.16B		-
CLOUDWALK TECHNOLOGY CO., LTD.	-31.79%	1.64B	-	-
XOMETRY, INC.	-66.40%	589M		C
BAIRONG INC.	-33.21%	557M		-
SELVAS AI INC.	-22.52%	295M		-
VUNO INC.	-36.79%	265M		-
SALTLUX INC.	-27.89%	167M	-	-
ALMAWAVE S.P.A.	+6.04%	139M		-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality